Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies

Objectives To examine the association between dipeptidyl peptidase-4 (DPP-4) inhibitors and the risk of heart failure or hospital admission for heart failure in patients with type 2 diabetes. Design Systematic review and meta-analysis of randomised and observational studies. Data sources Medline, Em...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMJ
Asıl Yazarlar: Li, Ling, Li, Sheyu, Deng, Ke, Liu, Jiali, Vandvik, Per Olav, Zhao, Pujing, Zhang, Longhao, Shen, Jiantong, Bala, Malgorzata M, Sohani, Zahra N, Wong, Evelyn, Busse, Jason W, Ebrahim, Shanil, Malaga, German, Rios, Lorena P, Wang, Yingqiang, Chen, Qunfei, Guyatt, Gordon H, Sun, Xin
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Publishing Group Ltd. 2016
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4772781/
https://ncbi.nlm.nih.gov/pubmed/26888822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmj.i610
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller